MCL 0020

CAS: 475498-26-1

Ref. 3D-AUA49826

Produktinformation

• Name: MCL 0020

Beschreibung

MCL 0020 is a small molecule drug that has been shown to alleviate the cognitive deficits in a transgenic mouse model of Alzheimer's disease. MCL 0020 binds to the element binding protein and increases the levels of melanocortin, which enhances long-term potentiation and synaptic plasticity. MCL 0020 also modulates synaptic dysfunction and reverses synaptic loss in a transgenic mouse model of Alzheimer's disease. The potential for MCL 0020 as an Alzheimer's treatment is highlighted by its ability to significantly improve cognitive function in mice with an app/ps1 transgenic, which mimics early-stage Alzheimer's pathology.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 609.73 g/mol
• Formel: C₃₄H₃₉N₇O₄
• Reinheit: Min. 95%